MERCILON

This brand name is authorized in Austria, Brazil, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, UK.

Active ingredients

The drug MERCILON contains a combination of these active pharmaceutical ingredients (APIs):

1	Desogestrel UNII 81K9V7M3A3 - DESOGESTREL
	Desogestrel is a progestogen. Like other progestogen-only pills, desogestrel is best suited for use during breast feeding and for women who may not or do not want to use oestrogens. In contrast to traditional progestogen-only pills, the contraceptive effect of desogestrel is achieved primarily by inhibition of ovulation. Other effects include increased viscosity of the cervical mucus.
	Read more about Desogestrel
2	17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL
	Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.
	Read more about 17 alpha-Ethinylestradiol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03AA09	Desogestrel and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	527302101113413, 527303801119315, 527316010018103, 527316010018203
EE	Ravimiamet	1062908, 1062919
FI	Lääkealan turvallisuus- ja kehittämiskeskus	109744, 110395
FR	Base de données publique des médicaments	69374160
GB	Medicines & Healthcare Products Regulatory Agency	139308, 26196
HK	Department of Health Drug Office	33400
IE	Health Products Regulatory Authority	31402
IL	מִשְׂרַד הַבְּרִיאוּת	3029, 3030
LT	Valstybinė vaistų kontrolės tarnyba	1013172, 1013173, 1013174, 1064031, 1085686, 1085792
MT	Medicines Authority	MA031/02301, PI770/10101B, PI908/12802A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	001M93
NL	Z-Index G-Standaard, PRK	78328
NZ	Medicines and Medical Devices Safety Authority	3410
PL	Rejestru Produktów Leczniczych	100042774, 100065440, 100266427, 100267970, 100290667, 100292703, 100314333, 100334130, 100344268, 100377055, 100417470, 100417978, 100419902, 100422040
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68120001, W68120002, W68120003
SG	Health Sciences Authority	06136P
ZA	Health Products Regulatory Authority	Y/18.8/78